Leukemia, Myeloid, Acute: all 3,035 studies
Page 3 of 31. Open to participants first (746), then studies with results posted, then the rest; newest registration first within each.
- High-dose Ascorbate (HDA) in Combination With Standard of Care Azacitidine and Venetoclax in Acute Myeloid Leukemia (AML)RecruitingNCT07177079Phase 1
- Alternating Regimen of VA and Low-dose CHA in the Treatment of Unfit Newly Diagnosed AMLRecruitingNCT07172204Phase 2
- Radioimmunotherapy Conditioning With 131I- Apamistamab for Allogeneic Transplant in Relapse/Refractory AMLNot yet recruitingNCT07157514Phase 2/3
- Study of AZD3632 Monotherapy or in Combination With Anticancer Agents in Participants With Advanced Haematologic Malignancies With KMT2Ar, NPM1m, or Other Genotypes Associated With HOX OverexpressionRecruitingNCT07155226Phase 1/2
- A Longitudinal Multi-Center Molecular Biomarker Discovery Registry for Patients With Hematologic MalignanciesRecruitingNCT07154823
- Testing the Use of an IDH1 Inhibitor, Olutasidenib, in Acute Myeloid Leukemia Added to ASTX727 and Venetoclax; in High-Risk MDS Added to ASTX727; and Alone in Low Risk MDS (A MyeloMATCH Treatment Substudy)Not yet recruitingNCT07153497Phase 2
- SupCD7 CART for Relapsed or Refractory CD7 Positive Hematologic MalignanciesRecruitingNCT07153068Phase 1/2
- Harmonized Clinical and Biological Database for Integrated Research Into the Management of Pediatric Acute Myeloid LeukemiaNot yet recruitingNCT07150676
- A Multi-Site Break Through Cancer Trial: Targeting Measurable Residual Disease in Patients With Acute Myeloid Leukemia: A Phase 1/2 Study of Tagraxofusp, Azacitidine, and VenetoclaxRecruitingNCT07148180Phase 1/2
- Evaluation of Chemotherapy-induced Cognitive Disorders During the Treatment of Hematological MalignanciesRecruitingNCT07147621
- Expression Pattern and Possible Clinical Significance of CD81 In Myeloid LeukemiaNot yet recruitingNCT07146542
- HPC Offered for PRESERVE ExpansionRecruitingNCT07145411
- Donor Derived CD117 CAR-T Cells in the Treatment of R/R Acute Myeloid LeukemiaRecruitingNCT07144020Early Phase 1
- Prognostic Impacts of Lipid Profile and BMI in Adult AMLNot yet recruitingNCT07143877
- HPB-092 for the Treatment of Relapsed and Refractory Acute Myeloid LeukemiaRecruitingNCT07137637Phase 1
- Comparison of VA and D/IA Induction Regimens in Elderly Fit Acute Myeloid Leukemia PatientsRecruitingNCT07132684Phase 3
- MRD-positive AML Clinical StudyRecruitingNCT07131059Not applicable
- Olutasidenib Single Plus Combo Therapy in IDH1mut AML After Induction and ConsolidationRecruitingNCT07130695Phase 1
- The Efficacy and Safety Assessment of Allogeneic γδ T Cells in Patients With MRD-positive AML After Allo-HSCTRecruitingNCT07126782Early Phase 1
- Home Blood TransfusionsRecruitingNCT07121140Not applicable
- Venetoclax-Decitabine in Untreated Elderly/Unfit AMLRecruitingNCT07117422Not applicable
- Molecular Characterization of Carbapenemase-Producing EnterobacteralesNot yet recruitingNCT07116356Not applicable
- The Prognostic Significance of Platelet to White Blood Cell Ratio (PWR) in Patients With Acute Myeloid LeukemiaNot yet recruitingNCT07115537
- uCD7 CART for Relapsed or Refractory CD7 Positive Hematologic MalignanciesRecruitingNCT07109518Phase 1
- Efficacy of Integrated Induction-Consolidation Chemotherapy and Transplantation for Adult Acute Myeloid Leukemia: Multicenter StudyRecruitingNCT07108530Phase 2
- Safety and Proof-of-Concept Study of RPT1G in Adults With Acute Myeloid Leukemia and High-Risk Myelodysplastic SyndromesRecruitingNCT07107126Phase 1
- CD180 CART for Relapsed or Refractory CD180 Positive Hematologic MalignanciesRecruitingNCT07106749Phase 1
- Randomization for the Identification of Best Treatment Intensity for Less Fit Adults With Acute Myeloid Leukemia and Myeloid NeoplasmsRecruitingNCT07094750Not applicable
- Ex Vivo T-Cell-Depleted Haploidentical Transplantation Bridging With Chimeric Antigen Receptor T-cell Therapy and Prophylactic Memory T Cell Infusion for Acute LeukemiaNot yet recruitingNCT07087847Not applicable
- A Multicenter Trial Evaluating Efficacy and Safety of A Reduced Venetoclax Exposure To Seven Days Versus Standard Continuous Venetoclax Exposure Combined With Azacitidine in Treatment Naïve Subjects With Acute Myeloid Leukemia Who Are Ineligible for Intensive InductionNot yet recruitingNCT07082452Phase 3
- Observational Study on APL-like aCute Myeloid Leukemia: disTInct Phenotype and Early VAscular complicaTionsRecruitingNCT07080970
- Venetoclax-containing Therapy Combined With Microtransplant for Newly Diagnosed AMLRecruitingNCT07078591Phase 2
- Ivosidenib and Azacitidine With or Without Venetoclax in Adult Patients With Newly Diagnosed IDH1-Mutated AML or MDS/AML Considered Ineligible for Intensive ChemotherapyRecruitingNCT07075016Phase 3
- Repurposing Itraconazole as an Adjuvant Therapy in Treatment of Patients With Acute Myeloid Leukemia: Is it a Hopeful Avenue for Enhancing Treatment Options?Not yet recruitingNCT07069933Phase 2
- Efficacy of Hypomethylating Agents vs. Intensive Chemotherapy in Acute Myeloid Leukemia Using 5hmC as a Blood-Based Minimal Residual Disease MarkerRecruitingNCT07060001Phase 2
- UPDATE AML: UPdated Disease Monitoring And Treatment for Enhanced Outcomes for Pediatric AMLRecruitingNCT07059975Early Phase 1
- A Phase 1 Open-Label, Dose-Ranging Safety and Pharmacokinetics Study of Oral Cladribine in Patients With Acute Myeloid Leukemia (AML)Not yet recruitingNCT07053020Phase 1/2
- Combination Chemotherapy (FLAG-Ida) Followed Immediately by Reduced-Intensity Total Body Radiation Therapy and Donor Hematopoietic Cell Transplant for the Treatment of Adults Age 60 and Older With Newly Diagnosed Adverse-Risk Acute Myeloid Leukemia or Other High-Grade Myeloid CancerRecruitingNCT07046078Phase 2
- Study to Assess Adverse Events and Change in Disease Activity of Oral Venetoclax in Combination With Subcutaneous (SC) or Intravenous (IV) Azacitidine in Newly Diagnosed Adult Participants With Acute Myeloid Leukemia (AML) Who Are Ineligible for Standard Induction Therapy in IndiaRecruitingNCT07044687Phase 4
- Trial of Novel Anti-leukemia Agents in Flu/Mel RIC Transplant for Myeloid MalignanciesRecruitingNCT07044544Phase 1
- Clinical Study of U32 in Patients With Acute Myeloid LeukemiaRecruitingNCT07036250Phase 1/2
- VAM in Secondary AML, AML With Extramedullary Involvement, and Myeloid SarcomaRecruitingNCT07028086Phase 2
- A New Treatment of Newly Diagnosed KIT Mutation CBF-Acute Myeloid LeukemiaRecruitingNCT07028073Phase 1/2
- Phase I/II Clinical Trial of Universal Donor CD33 CAR Natural Killer Cells for AMLNot yet recruitingNCT07026942Phase 1/2
- Evaluation of Treosulfan Versus Melphalan Conditioning Followed by PTCy in Patients With AML and MDS Undergoing Allogeneic TransplantationRecruitingNCT07025824Phase 2
- MiRisten for the Treatment of Relapsed or Refractory Acute Myeloid LeukemiaRecruitingNCT07025564Phase 1
- Study on Optimizing the Treatment of Patients With Acute Myeloid Leukemia Based on Early Peripheral Blood Minimal Residual DiseaseRecruitingNCT07023588Phase 2
- Xylitol Dental Wipes for the Reduction of Bloodstream Infection Risk in Children With Acute Myeloid LeukemiaRecruitingNCT07022678Phase 3
- A Vaccine (CMV-MVA Triplex Vaccine) for the Enhancement of CMV-Specific Immunity and the Prevention of CMV Viremia in Patients Undergoing Haploidentical Hematopoietic Stem Cell TransplantRecruitingNCT07020533Phase 1
- Study of Individuals and Families With Aberrations in DDX41 or Similar Cancer Predisposition VariantsRecruitingNCT07019155
- Ciprofloxacin vs Ceftazidime for Empirical Treatment of High-Risk Neutropenic Fever in Children With Hematologic MalignanciesRecruitingNCT07016165Phase 4
- A Phase 1B Investigator Initiated Study of Safety and Tolerability of Dexamethasone (D) in Combination With Venetoclax-based Low-Intensity Therapy (LIT) in Treatment-Naïve Acute Myeloid Leukemia (AML): DLIT-AMLEnrolling by invitationNCT07014462Phase 1
- Clinical Trial of WBC100 Capsule in Relapsed/Refractory Acute Myeloid LeukemiaRecruitingNCT07014449Phase 1
- A Study to Find the Highest Dose of Cedazuridine and Decitabine Combination With Filgrastim as a Treatment Option After Hematopoietic Stem Cell Transplant in Children With High-Risk Acute Myeloid LeukemiaRecruitingNCT07012044Phase 1
- A Study of Natural Killer Cells in Combination With Atezolizumab in People With Acute Myelogenous LeukemiaRecruitingNCT07011004Phase 1
- Phase I/II Clinical Trial of Proteasome Inhibitor in Combination With CPX-351 for the Treatment of Newly-Diagnosed TP53-mutated Acute Myeloid Leukemia (AML)RecruitingNCT07008638Phase 1/2
- a New Treatment of Newly Diagnosed IDH1 Mutation Acute Myeloid LeukemiaRecruitingNCT07007949Phase 2
- Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AMLRecruitingNCT07007312Phase 3
- Emapalumab With Post-Transplant Cyclophosphamide, Tacrolimus and Mycophenolate Mofetil for the Prevention of Graft-versus-Host Disease After Donor Reduced-Intensity Hematopoietic Cell TransplantRecruitingNCT06996119Phase 1
- A Study of CBX-250 in Participants With Relapsed or Refractory Myeloid LeukemiasRecruitingNCT06994676Phase 1
- Effectiveness of Medium-Dose Cytarabine Combined With Venetoclax for Consolidation Therapy in Elderly Patients With Intermediate to High-Risk Acute Myeloid LeukemiaRecruitingNCT06990321Phase 3
- RVU120 Rollover StudyEnrolling by invitationNCT06987058Phase 2
- XP-005 Personalized Vaccine Alone or in Combination With Toripalimab for the Prevention of Relapse After Remission in Acute Myeloid LeukemiaRecruitingNCT06980155Early Phase 1
- A Study to Assess the Safety, Tolerability, and Antileukemic Activity of Debio 1562M in Participants With Acute Myeloid Leukemia (AML)RecruitingNCT06969430Phase 1/2
- Registry of Myelodysplastic Syndromes and Therapy-related Acute Myeloid LeukemiaRecruitingNCT06956755
- Venetoclax or Placebo in Combination With Reduced-Intensity Conditioning Hematopoietic Cell (Bone Marrow/Blood Stem Cell) Transplant and as Maintenance Therapy After Transplant in Patients With Acute Myeloid Leukemia (A MyeloMATCH Treatment Trial)Not yet recruitingNCT06954987Phase 2
- A Phase 1 Study of STX-0712 in Patients With Advanced Hematological Malignancies (CMML and AML)RecruitingNCT06950034Phase 1
- ONC-LEUK-2406: The Impact of Systematic Financial Navigation in Acute Myeloid LeukemiaRecruitingNCT06945042Not applicable
- Ziftomenib for the Treatment of Patients With NPM1 Mutated or KMT2A Rearranged Acute Myeloid Leukemia Not Eligible for Standard TherapyRecruitingNCT06930352Phase 2
- Leukemia Adapted ProtocolRecruitingNCT06928909
- Chemotherapy (Decitabine in Combination With FLAG-Ida) and Total-Body Irradiation Followed by Donor Stem Cell Transplant for the Treatment of Adults With Myeloid Malignancies at High Risk of RelapseRecruitingNCT06928662Phase 1/2
- A Multicenter RCT of "3+7" vs Venetoclax + CACAG in Newly Diagnosed Mid/High-Risk AML PatientsRecruitingNCT06928376Phase 2
- The Application of CAR-T Cell Therapy in Relapsed and Refractory Malignant Hematologic TumorsRecruitingNCT06911710Phase 1/2
- A Long-term Follow-up Study of Patients With ARD103 CAR-T Cell TherapiesNot yet recruitingNCT06906380
- Co-Transplant of an Unmodified Haplo-Identical Graft With Cord BloodRecruitingNCT06904482Phase 2
- Autologous T Cells Transduced With Retroviral Vectors Expressing TCRs for Participant-specific Neoantigens in Patients With Hematologic MalignanciesRecruitingNCT06904066Phase 1
- Gut Health in Children With CancerRecruitingNCT06899581
- Anti-NKG2A Monoclonal Antibody for AML or MDS Patients Undergoing Haploidentical TransplantationRecruitingNCT06892223Phase 2
- Massage Impact on Sleep in Pediatric OncologyRecruitingNCT06892158Not applicable
- Epidemiological Study of a Prospective Cohort of Patients Aged 60 and Over Managed for Acute Myeloid Leukemia (AML) and Receiving Intensive Induction TherapyRecruitingNCT06891144
- Involvement of CDA and/or dCK Metabolizing Enzymes in the Response to Azacytidine Treatment of Patients With Hematologic MalignanciesRecruitingNCT06886425Not applicable
- Infusion of Alloreactive nk Cells for Mrd-positive Aml PatientsRecruitingNCT06885476Not applicable
- A Clinical Study to Evaluate the Safety and Efficacy of CLL1 and CD38 Dual-Target CAR-T Cell Injection in the Treatment of Relapsed or Refractory Acute Myeloid LeukemiaRecruitingNCT06880354Phase 1
- A Single-arm, Prospective Study of TBI + BUMEL As a Conditioning Regimen for Salvage HSCT in Patients with R/R AMLRecruitingNCT06879847Not applicable
- Targeting Acute Myeloid Leukemia Immunosuppressive Microenvironment by combinedIDO1 Inhibition and PD-1 BlockadeRecruitingNCT06874257
- Genetically Engineered Cells (CD83 CAR T Cells) for the Treatment of Relapsed or Refractory Acute Myeloid LeukemiaRecruitingNCT06871410Phase 1
- Thiotepa Combined With Busulfan and Fludarabine Conditioning Regimen for Haploidentical Hematopoietic Stem Cell Transplantation in Elderly Patients With High-Risk Acute Myeloid LeukemiaRecruitingNCT06869265Phase 2
- A Platform Protocol to Investigate Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis in Patients With Hematologic Malignancies Undergoing Mismatched Unrelated Donor Peripheral Blood Stem Cell TransplantationRecruitingNCT06859424Phase 2
- A Study of Bleximenib, Venetoclax and Azacitidine For Treatment of Participants With Newly Diagnosed Acute Myeloid Leukemia (AML)RecruitingNCT06852222Phase 3
- Effectiveness of Early Intervention in Palliative Care for Acute Myeloid Leukemia Patients Comparing to Standard of CareNot yet recruitingNCT06848270Not applicable
- Phase 1 Study of AUTX-703 in Relapsed/Refractory AML and MDSRecruitingNCT06846606Phase 1
- Safely Delivered Targeted High-dose Irradiation Followed by Adoptive Immunotherapy with Regulatory and Conventional T Cells to Increase Potency of Hematopoietic Stem Cell Transplantation in High-risk Acute LeukemiaRecruitingNCT06845592Not applicable
- Study of Tretinoin Capsules in Combination With Azacitidine and Venetoclax in Treatment Naïve Participants With Acute Myeloid LeukemiaNot yet recruitingNCT06841952Not applicable
- CD123-CD16-NK Cells Immunotherapy for AMLRecruitingNCT06835140Phase 1
- CER-1236 in Patients With Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome (MDS), and Myelofibrosis (MF)RecruitingNCT06834282Phase 1
- Veneclax, Chidaniline Combined With Azacitidine Followed by Decitabine + MAG Regimen in the Treatment of Elderly Untreated AMLRecruitingNCT06827899Phase 2
- Evaluation of Two Dose Levels of Quizartinib as Maintenance in FLT3-ITD (+) Acute Myeloid Leukemia Patients in Complete RemissionRecruitingNCT06824168Phase 2
- A Study of XS-04 in Patients With Relapsed or Refractory Hematologic MalignanciesRecruitingNCT06820268Phase 1
- Study on the Efficacy and Safety of the TmBU Conditioning Regimen in High-risk or Relapsed/Refractory Acute LeukemiaRecruitingNCT06816134Phase 2
- Vedolizumab Plus Post-transplant Cyclophosphamide and Short Course Tacrolimus for the Prevention of Graft Versus Host Disease in Patients Undergoing Allogeneic Hematopoietic Cell Transplantation After Reduced Intensity ConditioningRecruitingNCT06815003Phase 2